Unique ID issued by UMIN | UMIN000014401 |
---|---|
Receipt number | R000011295 |
Scientific Title | A study of Sentinel Node Navigation Surgery for Early Gastric Cancer |
Date of disclosure of the study information | 2014/06/27 |
Last modified on | 2019/07/26 10:28:42 |
A study of Sentinel Node Navigation Surgery for Early Gastric Cancer
A study of Sentinel Node Navigation Surgery for Early Gastric Cancer
A study of Sentinel Node Navigation Surgery for Early Gastric Cancer
A study of Sentinel Node Navigation Surgery for Early Gastric Cancer
Japan |
Clinically T1N0 gastric cancer
Gastrointestinal surgery |
Malignancy
NO
To assess the availability and safety of the individuarized gastrectomy based on sentinel node concept for the early gastric cancer
Bio-equivalence
Confirmatory
Pragmatic
Phase II,III
Postoperative 5-year recurrence free survival(RFS) ratio
postoperative 3-year RFS rate, postoperative 3/5-year overall survival, sentinel node detection rate, distribution, sensitivity, accuracy for lymph node metastases, quality of life after surgery
Interventional
Parallel
Non-randomized
Open -no one is blinded
Active
3
Treatment
Maneuver |
Minimized gastrectomy and sentinel basin resection group :
for the patients whose sentinel nodes were negative by intraoperative pathological diagnosis and spread within the confines of the resection range of minimized surgery.
Conventional gastrectomy and sentinel basin resection group :
for the patients whose sentinel nodes were negative by intraoperative pathological diagnosis and spread beyond the confines of the resection range of minimized surgery.
Conventional gastrectomy group :
for the patients whose sentinel nodes were positive by intraoperative pathological diagnosis.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
1) Clinically diagnosed T1N0 early gastric cancer
2) Single lesion
3) Less than 40mm in size
4) Provided written informed concent
5) Histopathological type does not matter
1) Pregnancy, severe drug allergy, asthoma.
2) Multiple lesion
3) With prior treatment to same lesion
4) Synchronous or metachronous (within 5 years) malignancies.
5) Judged as irrelevant object for this study
6) Refusal of the trial entry
7) Remnant gastric cancer
8) Absolute indication for endoscopic treatments
225
1st name | Hirofumi |
Middle name | |
Last name | Kawakubo |
School of Medicine, Keio University
Department of Surgery
160-8582
35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
03-3353-1211
hkawakubo@z3.keio.jp
1st name | Hirofumi |
Middle name | |
Last name | Kawakubo |
School of Medicine, Keio University
Department of Surgery
160-8582
35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
03-3353-1211
hkawakubo@z3.keio.jp
School of Medicine, Keio University
None
Self funding
Keio University School of Medicine, Ethics Committee
35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
03-5363-3503
med-rinri-jimu@adst.keio.ac.jp
NO
鹿児島大学医学部・歯学部附属病院(鹿児島県)、国立大学法人三重大学医学部附属病院(三重県)、岩手医科大学附属病院(岩手県)、東京医科大学病院(東京都)、石川県立中央病院(石川県)、千葉大学医学部附属病院(千葉県)、防衛医科大学校病院(埼玉県)、公立大学法人福島県立医科大学附属病院(福島県)、金沢大学附属病院(石川県)、東海大学医学部附属病院(神奈川県)、埼玉メディカルセンター(埼玉県)、東京慈恵会医科大学附属病(東京都)、東京慈恵会医科大学附属柏病院(千葉県)、金沢医科大学(石川県)
2014 | Year | 06 | Month | 27 | Day |
Unpublished
Terminated
2013 | Year | 09 | Month | 01 | Day |
2014 | Year | 05 | Month | 26 | Day |
2014 | Year | 05 | Month | 26 | Day |
2025 | Year | 05 | Month | 26 | Day |
2014 | Year | 06 | Month | 27 | Day |
2019 | Year | 07 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011295
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |